Page 1459 - Problem-Based Feline Medicine
P. 1459

1452           INDEX


          Mucoperiosteal pedicle flap, oronasal  pathogenesis, 1085    Myocardial depression, lignocaine,
             fistulas, 28                 prognosis, 1086                 1348
          Mucopolysaccharidosis, 977, 988–989  treatment, 408, 1086    Myocardial hypertrophy, 136
          Mucopolysaccharidosis VI, 921   see also specific types      Myocardial infarction, 135
          Mucosal cytoprotectants       Mycobacterial keratitis (Florida spots),  Myocarditis, 367, 380
           esophagitis, 616                 1235, 1251–1252, 1264      Myoglobin, discolored urine, 207, 208
           gastritis/gastric ulcers, 680  clinical signs, 1255, 1264   Myoglobinuria, 213
           hereditary myopathy of the Devon  cloudy cornea, 1264       Myopathy, 61–62
               Rex, 627                   diagnosis, 1264                degenerative, 942, 964–966
           non-steroidal anti-inflammatory  Mycobacterium bovis, 1093    dyspnea/tachypnea, 48, 61–62
               drug toxicity, 657       Mycoplasma, 14, 38–39            hereditary, 942, 964–966
          Mucus membranes                 chronic infection, 20, 29–30   hereditary in the Devon Rex see
           cherry-red, 99                 clinical signs, 6, 12, 14, 30, 33, 38  Devon Rex myopathy
           tetralogy of Fallot, 149       cystitis/urethritis, 187       hypernatremic see Hypernatremic
          Multiple myeloma, hyperviscosity  diagnosis, 14, 30, 38           myopathy
             syndrome, 1187               differential diagnosis, 14     hypokalemic see Hypokalemic
          Murmurs, definition, 124        lymphadenopathy, 395, 417         myopathy
          Muscle biopsies, polymyositis, 898  pathogenesis, 14           nemaline rod, 965, 966
          Muscle relaxants, tetanus, 1340  sneezing/nasal discharge, 14  Myotonia, 866, 967
          Muscular contusions, 978, 980–981  stridor, 38–39              clinical signs, 866, 944, 967
          Muscular dystrophy, 964–966     treatment, 14                  diagnosis, 866, 967
          Musculoskeletal abnormalities, feline  Mycoplasma conjunctivitis, 1218–1219  differential diagnosis, 866, 967
             leukemia virus, 543          bulbar conjunctiva, red coloration,  pathogenesis, 866, 967
          Mutton fat deposits see Keratic    1197                        tremor/twitching, fine
             precipitates (KPs; “mutton fat  differential diagnosis, 1216, 1222  (unintentional), 853, 866
             deposits”)                   ocular discharge/changed       weakness, generalized, 967
          Myasthenia gravis, 62, 622–623,    conjunctival appearance, 1208,
                                                                       N
             866–867, 896–897, 955–956       1218–1219
           acquired, 891, 896–897, 955    third eyelid, 1333–1334      Nadolol, 1385
           clinical signs, 622, 866–867, 896,  Mycoplasma felis, 14    Nafcillin, 1385
               943, 955–956             Mycoplasma felis conjunctivitis, 1213,  Nails
           congenital, 890, 896–897, 955    1218                         avulsed, 1110, 1111
           diagnosis, 622, 867, 896–897, 956  Mycoplasma gatae, 14, 984  shorn, 266
           differential diagnosis, 622, 897, 898,  Mycoplasma gatae conjunctivitis,  shredded tips, 1110, 1111
               956                          1213–1214, 1218            Nalbuphine hydrochloride, 1385
           neck ventroflexion, 896–897  Mycoplasma haemofelis          Nalorphine, 1385
           pathogenesis, 896, 955           (Haemobartonella felis), 262, 270  Naloxone, 1057, 1385
           prevention, 956                anemia, 424–425, 530         Naltrexone, 1385
           prognosis, 897, 956            hemoplasmosis, 530, 532      Nandrolone decanoate, 1385
           regurgitation, 613, 622–623  Mycoplasma haemominutum        Naproxen poisoning, 657
           treatment, 622–623, 897, 956     (Haemobartonella felis), 366, 374  Narcotics, esophagitis, 592
           tremor/twitching, fine         immune-mediated anemia, 424–425  Nasal cavity examination, 269
               (unintentional), 854, 866–867  jaundice/elevated liver enzymes, 421  Nasal discharge, 5–18
           weakness, generalized, 955–956  pyrexia, 374                  bacterial rhinitis and sinusitis, 356
          Mycobacterial infections, 407–408,  Mycoplasma pneumonia, 62   calicivirus, 371
             1085–1086                  Mydriasis                        cryptococcosis, 379
           clinical signs, 407, 1085      definition, 1281               foreign bodies inhalation, 98
           diagnosis, 407, 1085–1086      diseases causing, 883–888      infectious upper respiratory tract
           differential diagnosis, 408, 1086  thiamine deficiency, 848      disease, 55
           lymphadenopathy, 407–408     Mydriatics, 1286                 oronasal fistula, 610
           lymph nodes, enlarged, 395   Myelopathy, localization of, 908  Nasal disease, chronic, 19–31
           non-healing wounds, 1083,    Myelophthitic diseases, 529, 546–547  see also specific diseases/disorders
               1085–1086                Myiasis, 1319, 1329            Nasal flushing, foreign bodies, 16, 28
   1454   1455   1456   1457   1458   1459   1460   1461   1462   1463   1464